The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMMC.L Regulatory News (MMC)

  • There is currently no data for MMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

30 Jun 2009 07:00

RNS Number : 7121U
Management Consulting Group PLC
30 June 2009
 



30 June 2009

Management Consulting Group PLC

Pre-Close Trading Update

Pre-Close Trading Update 

Management Consulting Group PLC ('MCG' or 'the Group') issues the following pre-close period trading update ahead of the announcement of the Group's 2009 interim results which are due to be announced on 3 August 2009.

Trading by Division

Alexander Proudfoot (formerly Proudfoot Consulting) has remained robust in the first half of 2009, particularly in the United StatesThe vast majority of its business remained the provision of 'cost base improvementprojects, emphasising the counter-cyclical nature of its offering. Revenue to June 2009 is expected to be broadly in line with 2008 but underlying* operating profit is expected to be higher than last year due to a combination of favourable exchange rates and benefits from the restructuring projects.

Ineum Consulting (combining Ineum Consulting, Parson Consulting and Viaduct Consulting as reported in 2008) has been resilient with the French business performing particularly wellAs previously reported, trading in the 'legacy' Parson US business was very slow at the beginning of the year and this business has now been closed. Losses in the first half of 2009 for this legacy business are expected to be around £1.6m and the underlying operating profit of Ineum Consulting as a whole is expected to be broadly in line with last year. 

As disclosed in both the preliminary results in March and the Interim Management Statement in April, trading in Kurt Salmon Associates has been adversely affected by the current economic downturn in both its consumer products and health care markets. This trend has continued throughout the first half of 2009. Although there has been a slight improvement in the order book of the consumer products division in the second quarter, the health care business, which relies on capital expenditure in the US health care sector, continues to find its market challenging as clients conserve cash pending conclusion of the important national health reform debate later in the year. As a result of these factors, revenue for the first half of 2009 is expected to be between 20% and 25% below the corresponding figure for 2008 (and between 35% and 40% down in constant exchange rate terms) and the division is anticipated to be loss making for this period. However, Kurt Salmon Associates expects to return to profitability in the second half of the year and, although statistics for the period are not yet available, management does not believe it has lost market share.

Restructuring Programmes

The management of MCG has continued to be proactive in its restructuring of the business to mitigate the effects of the economic downturn on the short and longer term results of the business. Several programmes have been undertaken in the first half of 2009 with the result that the numbers employed worldwide in the Group are expected to be around 1,850 at the end of June, down around 300 or 14% from the number employed at the end of 2008 and around 500 or 21% from twelve months ago. The majority of this reduction has occurred in the US

As previously reported the 'legacy' Parson US business has now been closed and it is only the CBH Consulting business, acquired in 2007, that remains active in this space. This has also involved a restructuring of the IT infrastructure in the US that used to be run in tandem with the Alexander Proudfoot systems. 

Also as previously reported Kurt Salmon Associates has undertaken a substantial redundancy programme. In view of the continued soft trading this programme has been extended to cover both the US and European businesses.

In addition Alexander Proudfoot has taken the decision to close its Australian office due to the completion of its ongoing projects. The Australian business will now largely be run out of the global Natural Resource Centre of Excellence. As a result Ineum Consulting will be relocating its Sydney office to smaller premises. Alexander Proudfoot has also undertaken redundancy programmes, particularly in Europe where demand has been weak.

As a result of the above measures, non-recurring costs for the first half of 2009 are expected to be in the region of £6to £7m (2008: £11.0m). 

Amortisation of intangibles is estimated to be approximately £1.4m (2008: £1.1m). No charge is expected relating to the impairment of acquired goodwill (2008: £26.7m). Underlying earnings per share for the first half of 2009 is expected to be between 1.8p and 2.2p per share (2008: 2.8p)

Net Debt

Net debt is expected to be around £80m at 30 June 2009 (2008: £78.9m). At constant exchange rates this represents a reduction of about £15m in the past twelve months, demonstrating the continued cash generative nature of the business despite the difficult trading conditions. The Group expects to be comfortably within its covenant and facility limits. The seasonal nature of the Group's working capital cycle means that net debt generally increases in the first half of the year and decreases in the second half. 

Outlook

While the Group has benefited in the first half of 2009 from the counter-cyclical nature of some of its businessesthe savings from previous restructuring programmes and the weakness in Sterling, this has been offset by the tough market conditions in the Kurt Salmon Associates business in particular. As a result revenue and underlying operating profit for the six months to 30 June 2009 are expected to be below those for the first half of 2008. The Group's revenue from continuing operations for the six-month period ended 30 June 2009 is estimated to be in the range of £150m to £160m (2008: £166.7m). Underlying operating profit is expected to be in the range of £11.5m to £12.5m (2008: £15.1m).

The recent strengthening of Sterling will, if it continues, adversely affect the reported revenue and profit of the Group for the full year but will reduce the net debt, which is held predominantly in US Dollars and Euros. The second half of 2009 also faces the challenge of being compared to a very strong second half performance in 2008, and the Group will start the period with an order book about ten percent lower than twelve months agoAs usual for MCG, visibility of this order book remains limited to three to four months and so forecasting results for the full year remains difficult although, given the above factors, the Board recognises that the Group may come in below market consensus for 2009. 

Management continues to take decisions appropriate to balance its short term profitability with its longer term prospects. Shareholder returns remain uppermost in the minds of the Directors and the Board continues to review and consider its options regularly as it looks to maximise these returns.

\* The term 'underlying' is defined as '"before non-recurring items, the amortisation of acquired intangible assets and the impairment of acquired goodwill from continuing operations."

For further information please contact:

Management Consulting Group PLC

Tel: +44 20 7710 5000

Craig Smith, Finance Director

Financial Dynamics

Tel: +44 20 7269 7242

Ben Atwell

Notes to editors:

Management Consulting Group PLC (MMC.L) is an umbrella organisation for a diverse range of consulting and professional services offerings.

MCG operates through three divisions: Ineum Consulting, Kurt Salmon Associates, and Alexander Proudfoot. Ineum Consulting provides consulting services with industry expertise. Kurt Salmon Associates provides retail and healthcare consulting. Alexander Proudfoot provides operational improvement consulting. The Group operates worldwide. For further information, visit www.mcgplc.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBUGDLSXDGGCC
Date   Source Headline
20th Dec 20127:00 amRNSTransaction in Own Shares
19th Dec 20127:00 amRNSTransaction in Own Shares
18th Dec 20127:30 amRNSTransaction in Own Shares
17th Dec 201212:09 pmRNSHolding(s) in Company
10th Dec 20127:00 amRNSTransaction in Own Shares
7th Dec 20127:00 amRNSTransaction in Own Shares
6th Dec 20127:00 amRNSTransaction in Own Shares
3rd Dec 201210:04 amRNSTotal Voting Rights
29th Nov 20127:00 amRNSTransaction in Own Shares
27th Nov 20127:00 amRNSTransaction in Own Shares
26th Nov 20127:00 amRNSTransaction in Own Shares
23rd Nov 20127:00 amRNSTransaction in Own Shares
22nd Nov 20127:00 amRNSTransaction in Own Shares
19th Nov 201211:18 amRNSHolding(s) in Company
15th Nov 20127:00 amRNSTransaction in Own Shares
9th Nov 20127:00 amRNSTransaction in Own Shares
5th Nov 201210:27 amRNSTransaction in Own Shares
30th Oct 20127:00 amRNSInterim Management Statement
31st Aug 20125:17 pmRNSDirector/PDMR Shareholding
13th Aug 20124:39 pmRNSHolding(s) in Company
2nd Aug 20127:00 amRNSHalf Yearly Report
18th Jun 20127:00 amRNSDirector/PDMR Shareholding
15th Jun 20124:40 pmRNSSecond Price Monitoring Extn
15th Jun 20124:35 pmRNSPrice Monitoring Extension
14th Jun 20127:00 amRNSDirector/PDMR Shareholding
13th Jun 20122:51 pmRNSTrading update
7th Jun 20127:00 amRNSProgress in healthcare practice in the US
4th May 20124:48 pmRNSHolding(s) in Company
26th Apr 20125:39 pmRNSHolding(s) in Company
19th Apr 20123:17 pmRNSResult of AGM
19th Apr 20121:30 pmRNSInterim Management Statement
12th Mar 20124:55 pmRNSDTR Notification
7th Mar 20127:00 amRNSFinal Results
6th Mar 20127:00 amRNSNotice of Results
6th Feb 20122:41 pmRNSHolding(s) in Company
31st Jan 20125:09 pmRNSTotal Voting Rights
9th Jan 201211:37 amRNSDirector/PDMR Shareholding
4th Jan 20127:00 amRNSPre-close statement
3rd Jan 20124:38 pmRNSDirector/PDMR Shareholding
3rd Jan 20127:00 amRNSTotal Voting Rights
23rd Dec 201110:33 amRNSHolding(s) in Company
21st Dec 20114:45 pmRNSDirector/PDMR Shareholding
7th Dec 20117:00 amRNSTotal Voting Rights
5th Dec 20115:06 pmRNSHolding(s) in Company
2nd Dec 20113:32 pmRNSHolding(s) in Company
2nd Dec 20117:00 amRNSTotal Voting Rights
1st Dec 20113:12 pmRNSDirector's Shareholdings
30th Nov 20116:22 pmRNSTotal Voting Rights
25th Nov 20114:12 pmRNSDirector/PDMR Shareholding
23rd Nov 20112:19 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.